Serum omentin levels predicts mesenteric ischemia

Abstract

Insights

Serum omentin levels may help diagnose acute mesenteric ischemia (AMI) early. Lower omentin levels were observed in rats with AMI, suggesting its potential as a diagnostic biomarker.

Area of Science:

  • Vascular Surgery
  • Gastroenterology
  • Metabolic Research

Background:

  • Acute mesenteric ischemia (AMI) presents diagnostic challenges and high mortality.
  • Omentin, a visceral adipose tissue protein, is linked to metabolic health.
  • Decreased serum omentin correlates with adverse metabolic outcomes.

Purpose of the Study:

  • To investigate if serum omentin levels can predict early AMI.
  • To assess omentin's role before transmural ischemia develops.

Main Methods:

  • A rat model with sham, transient ischemia, and permanent ischemia groups (n=8 each).
  • Serum analysis for urea, creatinine, omentin, and C-reactive protein (CRP).
  • Histological examination of ileal tissue.

Main Results:

  • Serum omentin levels were significantly lower in the ischemia-reperfusion group compared to the sham group (p=0.004).
  • No correlation was found between serum omentin and urea, creatinine, or CRP levels.

Conclusions:

  • Serum omentin may serve as a potential biochemical marker for early AMI detection.
  • Further clinical studies in humans are required to validate these findings.